Cite

HARVARD Citation

    Hew, M. et al. (n.d.). Real‐life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteria. Clinical & experimental allergy. 46 (11), pp. 1407-1415. [Online]. 
  
Back to record